Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02486302
What this trial is testing

Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+1 more
Pfizer 1,534
Early research (Phase 1)Study completedNCT02019602
What this trial is testing

A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta

Who this might be right for
Axial Spondyloarthritis (AxSpA)Non-radiographic Evidence-AxSpAAnkylosing Spondylitis+3 more
UCB BIOSCIENCES, Inc. 37
Post-approval studies (Phase 4)Looking for participantsNCT04119102
What this trial is testing

Duobrii in Combination With Biologics

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 25
Early research (Phase 1)Study completedNCT01045395
What this trial is testing

Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis

Who this might be right for
Psoriasis
University of Manitoba 30
Early research (Phase 1)Study completedNCT01836939
What this trial is testing

Safety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Mark Lebwohl 8
Testing effectiveness (Phase 2)Study completedNCT02223039
What this trial is testing

Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
AbGenomics B.V Taiwan Branch 50
Not applicableWithdrawnNCT02165657
What this trial is testing

Excimer Laser, Serum Markers & Psoriasis

Who this might be right for
Psoriasis
University Hospitals Cleveland Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT05044234
What this trial is testing

Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 156
Very early researchStudy completedNCT03114111
What this trial is testing

Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
University of California, Davis 12
Testing effectiveness (Phase 2)Study completedNCT01845987
What this trial is testing

The Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Janssen Pharmaceutical K.K. 49
Large-scale testing (Phase 3)Study completedNCT03504852
What this trial is testing

Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 331
Not applicableStudy completedNCT03939936
What this trial is testing

The Effect of Periodontal Treatment on Psoriasis

Who this might be right for
Periodontal Diseases
Ozge Gokturk 92
Post-approval studies (Phase 4)Study completedNCT01137032
What this trial is testing

Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population

Who this might be right for
PsoriasisAtopic Dermatitis
Fougera Pharmaceuticals Inc. 19
Not applicableStudy completedNCT01100034
What this trial is testing

Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis

Who this might be right for
Psoriasis
Pfizer 72
Not applicableStudy completedNCT07570706
What this trial is testing

Mucosal and Nasal Involvement and Their Correlation With Smell and Taste Functions in Lichen Planus Patients

Who this might be right for
Lichen Planus
Istanbul Training and Research Hospital 88
Testing effectiveness (Phase 2)Study completedNCT02111499
What this trial is testing

Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque Test

Who this might be right for
Psoriasis
Almirall, S.A. 18
Testing effectiveness (Phase 2)Study completedNCT00320216
What this trial is testing

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 320
Testing effectiveness (Phase 2)Ended earlyNCT03835481
What this trial is testing

Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is

Who this might be right for
Psoriasis
Boehringer Ingelheim 165
Post-approval studies (Phase 4)Study completedNCT01866592
What this trial is testing

Vascular Inflammation in Psoriasis - Extension Study

Who this might be right for
PsoriasisCardiovascular Disease
University of Pennsylvania 81
Large-scale testing (Phase 3)Study completedNCT01752634
What this trial is testing

Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 397
Next Page